Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban for prevention of venous thromboembolism after posterior lumbar interbody fusion in elderly patients
ChiCTR-IPR-17012975Phase 4Completed
- Sponsor
- Panyu Hospital of Traditional Chinese Medicine
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rivaroxaban in venous thromboembolism (VTE) (2 arms), sponsored by Panyu Hospital of Traditional Chinese Medicine. Primary endpoints: Wells score and Incidence of venous thromboembolism. Started Jan 2015; status: completed.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ChiCTR-IPR-17012975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012975.